Showing results (901-910 of 3,868) with videos related to
Sort By:
Pageof 387
Cancer Biology & Therapy|August 23, 2022
BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expressionShu-Cheng Liu, You-Han Cao, Li-Bo Chen, et al.Cancer Biology & Therapy|May 26, 2020
Identification of potential therapeutic targets in urothelial bladder carcinoma of Chinese population by targeted next-generation sequencingTao Wang, Zhengsheng Liu, Xuegang Wang, et al.Cancer Biology & Therapy|May 27, 2020
Transcriptional information underlying the generation of CSCs and the construction of a nine-mRNA signature to improve prognosis prediction in colorectal cancerWenbo Zheng, Chunzhao Yang, Ling Qiu, et al.Cancer Biology & Therapy|November 17, 2025
ARNTL2 regulated the oncogene c-myc and promoted the progression of esophageal cancer through activating ANXA2 transcriptionYanzi Qin, Hongfei Ci, Zhaoyi Wang, et al.Cancer Biology & Therapy|December 27, 2025
Downregulation of the lncRNA PGM5P4-AS1 predicts poor prognosis and drives breast cancer progression through miR-3664-5p/KLF9Yifan Wu, Jiangdong Jin, Yuhan Zhang, et al.Cancer Biology & Therapy|December 22, 2025
Identification of coilin in bone marrow as a potential neuroblastoma tumor progression marker transcriptionally regulated by MYCNZhixia Yue, Lan Li, Shuguang Liu, et al.Cancer Biology & Therapy|December 16, 2025
Novel perspectives on MSLN-targeted cancer therapy: from molecular mechanisms to clinical translationZhendong Wu, Xuefei Fu, Yuan Feng, et al.Cancer Biology & Therapy|July 7, 2025
Robust prediction of glioma prognosis by hypoxia-induced ferroptosis genes: VEGFA-XBP1 co-expression for salvage therapyZhou Liwei, Lu Hanwen, Zhao Wenpeng, et al.Cancer Biology & Therapy|June 23, 2025
β-hydroxybutyrate, a ketone body, suppresses tumor growth, stemness, and invasive phenotypes in non-small cell lung cancerYunlong Huang, Jiaxuan Ding, Yufeng Zhu, et al.Cancer Biology & Therapy|July 6, 2025
USP44 promotes chemotherapeutic drug resistance of triple negative breast cancer through EZH2 protein stabilityPu Wu, Wanting Xiao, Junjie Ni, et al.Pageof 387